[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100616448":3},{"organization":4,"armGroups":7,"interventions":27,"overallOfficials":38,"centralContacts":42,"locations":52,"responsibleParty":73,"collaborators":33,"id":76,"slug":77,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":78,"sex":84,"minAge":85,"maxAge":33,"enrollmentInfo":86,"targetDuration":33,"studyType":89,"phases":90,"briefSummary":92,"conditions":93,"keywords":97,"overallStatus":55,"whyStopped":33,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",[8,15,19,23],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort 1: CANCER SURVIVORS AGE 18-39 ON-TRAC SMALL GROUP","EXPERIMENTAL","Participants ages 18-39 will receive a group educational intervention via synchronous video conference that provides strategies for managing anxiety. 1-7 days after attending the educational session, participants will receive a 30- 45 minute individual coaching session by telephone to help them implement strategies to manage anxiety. After the first coaching session each participant will be offered a second (optional) coaching session.",[13,14],"Behavioral: ON-TRAC Education session","Behavioral: ON-TRAC Coaching",{"label":16,"type":10,"description":17,"interventionNames":18},"Cohort 2: CANCER SURVIVORS AGE 18-39 ON-TRAC INDIVIDUAL SESSIONS","Participants ages 18-39 will receive an individual, 1 on 1, educational intervention via synchronous video conference that provides strategies for managing anxiety. 1-7 days after attending their educational session, participants will receive a 30- 45 minute individual coaching session by telephone to help them implement strategies to manage anxiety. After the first coaching session each participant will be offered a second (optional) coaching session.",[13,14],{"label":20,"type":10,"description":21,"interventionNames":22},"Cohort 3: CANCER SURVIVORS AGE 40+ ON-TRAC SMALL GROUP","Participants ages 40+ will receive a group educational intervention via synchronous video conference that provides strategies for managing anxiety. 1-7 days after attending the educational session, participants will receive a 30-45 minute individual coaching session by telephone to help them implement strategies to manage anxiety. After the first coaching session each participant will be offered a second (optional) coaching session.",[13,14],{"label":24,"type":10,"description":25,"interventionNames":26},"Cohort 4: CANCER SURVIVORS AGE 40+ ON-TRAC INDIVIDUAL SESSIONS","Participants ages 18-39 will receive an individual, 1 on 1, educational intervention via synchronous video conference that provides strategies for managing anxiety. 1-7 days after attending their educational session, participants will receive a 30-45 minute individual coaching session by telephone to help them implement strategies to manage anxiety. After the first coaching session each participant will be offered a second (optional) coaching session.",[13,14],[28,34],{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"BEHAVIORAL","ON-TRAC Education session","120 minute educational session on strategies for anxiety delivered via synchronous videoconference session",[9,16,20,24],null,{"type":29,"name":35,"description":36,"armGroupLabels":37,"otherNames":33},"ON-TRAC Coaching","30-40 minute individual coaching sessions on implementation of strategies for anxiety",[9,16,20,24],[39],{"name":40,"affiliation":5,"role":41},"Christopher J Recklitis, PhD, MPH","PRINCIPAL_INVESTIGATOR",[43,48],{"name":44,"role":45,"phone":46,"phoneExt":33,"email":47},"On-Trac Study Coordinator","CONTACT","617-582-8260","ontrac@dfci.harvard.edu",{"name":49,"role":45,"phone":50,"phoneExt":33,"email":51},"Cheryl Medeiros-Nancarrow","617-632-5798","cheryl_nancarrow@dfci.harvard.edu",[53],{"facility":54,"status":55,"city":56,"state":57,"zip":58,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":67},"Dana Farber Cancer Institute","RECRUITING","Boston","Massachusetts","02115","United States","US",{"type":62,"coordinates":63},"Point",[64,65],-71.05977,42.35843,{"lat":65,"lon":64},[68,72],{"name":69,"role":45,"phone":70,"phoneExt":33,"email":71},"Christopher J Recklitis, Phd, MPH","617-632-3839","christopher_recklitis@dfci.harvard.edu",{"name":69,"role":41,"phone":33,"phoneExt":33,"email":33},{"type":41,"investigatorFullName":74,"investigatorTitle":75,"investigatorAffiliation":5,"oldNameTitle":33,"oldOrganization":33},"Christopher Recklitis, PhD","Principal Investigator","100616448","on-trac-an-online-intervention-for-cancer-survivors-managing-anxiety-100616448",false,"NCT07305740","On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety","Online Training After Cancer (On-Trac): Developing An Online Intervention for Cancer Survivors Managing Anxiety","On-Trac","Inclusion Criteria:\n\n* Age ≥ 18\n* A diagnosis of cancer (except non-melanoma skin cancer) ≥ 12 months prior.\n* No active cancer therapy (excluding chemoprevention) in the past 4 months, and no further therapy planned.\n* Significant anxiety as evidenced by both of the following\n\n  * Endorsement of the SCID ( Structured Clinical Interview for the DSM-5) Screener Items for Social Anxiety Disorder, Generalized Anxiety Disorder, Agoraphobia, Specific Phobia, or Illness Anxiety Disorder.\n  * A score ≥ 6 on the Overall Anxiety Severity and Impairment Scale (OASIS).\n* Regular access to the internet.\n* Ability to read and write in English.\n\nExclusion Criteria:\n\n* Significant symptoms of Panic Disorder in the prior month, including anticipatory anxiety of having a future panic attack or avoidance symptoms associated with panic attacks, as assessed by three SCID-5 items from the panic attack disorder module.\n* Significant symptoms of Obsessive Compulsive Disorder, as evidenced by any obsessions over the past 3 months, as assessed by three SCID items from the Obsessive Compulsive Disorder module.\n* Psychiatric hospitalizations or emergency room visits for psychiatric care in the prior 2 years.\n* In the next two months, intention to use or likelihood of using emergent or \"rescue\" anxiety medication (e.g., Ativan, Xanax, Valium) or self-prescribed substances (i.e., marijuana) at the onset of anxiety symptoms or when entering a situation where they expect to experience anxiety.\n* Any significant marijuana use which could impact anxiety symptoms, as evidenced by one of the following:\n\n  * 4 days of marijuana use in any week in the last month\n  * 20 milligrams of THC (Tetrahydrocannabinol) products in any week in the last month.\n* Participation in any CBT or ACT-based behavioral or education intervention for anxiety in the past 2 years. This includes in-person, asynchronous, and synchronous online anxiety programs, and therapy that includes these skills. This does not include independent use of any self-help materials (i.e., workbooks, books).\n* Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all parts of the study independently.","ALL","18 Years",{"count":87,"type":88},80,"ESTIMATED","INTERVENTIONAL",[91],"NA","This study is evaluating On-Trac (Online Training After Cancer), an online educational intervention to teach adult cancer survivors strategies to address anxiety based on Cognitive-Behavioral Therapy (CBT) and Acceptance Commitment Therapy (ACT)\n\nThe name of the study intervention is Online Training After Cancer (On-Trac)",[94,95,96],"Cancer","Survivorship","Anxiety",[98,96],"Cancer Survivorship","2026-05-12",{"date":101,"type":102},"2026-05-13","ACTUAL",{"date":104,"type":102},"2026-03-11",{"date":106,"type":88},"2027-12-31",{"name":5,"class":6},1]